BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24403086)

  • 21. Severe mitral valve insufficiency after transcatheter atrial septal defect closure with the amplatzer septal occluder: a device-related complication.
    Li W; Han W; Yu C; Zhang C; Tu Z; Wu S; Huber CH; Ma L
    J Card Surg; 2009; 24(6):672-4. PubMed ID: 20078713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Percutaneous catheter closure of atrial septal defect. Short-term and mid-term results].
    Bialkowski J; Kusa J; Szkutnik M; Kalarus Z; Banaszak P; Bermúdez-Cañete R; Fernández Pineda L; Zembala M
    Rev Esp Cardiol; 2003 Apr; 56(4):383-8. PubMed ID: 12689573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter closure of secundum atrial septal defects with the Amplatzer occluder in adult patients.
    Carcagnì A; Presbitero P
    Ital Heart J; 2002 Mar; 3(3):182-7. PubMed ID: 11974662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.
    Hill KD; Lodge AJ; Forsha D; Fleming GA; Green AS; Rhodes JF
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):654-9. PubMed ID: 22639441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter closure of secundum ASD using Occlutech Figulla-N device in symptomatic children younger than 2 years of age.
    Ammar RI; Hegazy RA
    J Invasive Cardiol; 2013 Feb; 25(2):76-9. PubMed ID: 23388225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical Removal of Embolized Ventricular Septal Occluder Device.
    Vaidhya N; Mishra A; Siddiqui S; Joshi H; Patel H
    World J Pediatr Congenit Heart Surg; 2017 Jul; 8(4):537-539. PubMed ID: 27198525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder.
    Nakayama R; Takaya Y; Akagi T; Watanabe N; Miki T; Nakagawa K; Toh N; Ito H
    Heart Vessels; 2021 May; 36(5):704-709. PubMed ID: 33386412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicentre, comparative study of Cera septal occluder versus AMPLATZER Septal Occluder in transcatheter closure of secundum atrial septal defects.
    Kaya MG; Akpek M; Celebi A; Saritas T; Meric M; Soylu K; Karapinar H; Lam YY
    EuroIntervention; 2014 Sep; 10(5):626-31. PubMed ID: 25022224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
    Pedra CA; Pedra SF; Costa RN; Ribeiro MS; Nascimento W; Campanhã LO; Santana MV; Jatene IB; Assef JE; Fontes VF
    J Interv Cardiol; 2016 Apr; 29(2):208-15. PubMed ID: 26927945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First experience with the new GORE Septal Occluder for the closure of multiple atrial septal defects.
    Freixa X; Garceau P; Asgar AW
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1238-42. PubMed ID: 22639117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial septal defect closure.
    Vasquez AF; Lasala JM
    Cardiol Clin; 2013 Aug; 31(3):385-400. PubMed ID: 23931101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic embolization of an atrial septal occluder device: percutaneous or surgical retrieval? A case report.
    Ussia GP; Abella R; Pome G; Vilchez PO; De Luca F; Frigiola A; Carminati M
    J Cardiovasc Med (Hagerstown); 2007 Mar; 8(3):197-200. PubMed ID: 17312438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
    El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous management of coronary sinus atrial septal defect: two cases representing the spectrum for device closure and a review of the literature.
    Sandeep N; Slack MC
    Cardiol Young; 2014 Oct; 24(5):797-806. PubMed ID: 24666783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of modified techniques of transcatheter closure in large atrial septal defects (⩾30 mm) with anatomic complexities.
    Ananthakrishna Pillai A; Upadhyay A; Gousy S; Handa A
    Cardiol Young; 2018 Oct; 28(10):1122-1133. PubMed ID: 30033909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A failed case of percutaneous septal closure of fenestrated atrial septal defect.
    Karabay CY; Izgi A; Dundar C; Aung SM; Tuncer A; Kirma C
    Cardiol J; 2011; 18(1):92-3. PubMed ID: 21305494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergent surgical removal of a migrated atrial septal defect occluder: case report.
    Wen B; He J
    J Cardiothorac Surg; 2020 Nov; 15(1):327. PubMed ID: 33176835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed embolisation of amplatzer ASD closure device caused partial obstruction of left ventricular outflow tract.
    Kim SH; Kim KH; Lim YM; Moon JY; Yang WI; Kim IJ; Lim SW
    Cardiovasc J Afr; 2014 Jun; 25(3):e1-3. PubMed ID: 25000522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial and ventricular septal defects device closure in a child in one session.
    Kumar V; Banerjee A; Aggarwal N; Garg S; Swamy A
    Indian Heart J; 2016; 68(3):370-2. PubMed ID: 27316495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial septal defect occluder device embolization: Experience of a tertiary care cardiac center.
    Garre S; Gadhinglajkar S; Sreedhar R; Krishnamoorthy KM; Pillai VV
    Ann Card Anaesth; 2023; 26(2):149-154. PubMed ID: 37706378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.